FDA approves TMS as form of OCD treatment
The FDA has approved Neuronetics’ transcranial magnetic stimulation system, called NeuroStar, as an adjunct treatment for adults with obsessive compulsive disorder. Neuronetics created NeuroStar as the first FDA-approved TMS system pioneered for major depressive disorder, the company said in a…